Search research articles
Contact Us
Filters
Showing results (1191-1200 of 22,015) with videos related to
Page
of 2,202
Sort By:
Oncogene
|
April 19, 2011
MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma
Y Zhai, A Iura, S Yeasmin, et al.
Oncogene
|
April 19, 2011
Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression
C Giordano, S Catalano, S Panza, et al.
Oncogene
|
April 19, 2011
Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate
E Babu, S Ramachandran, V CoothanKandaswamy, et al.
Oncogene
|
June 21, 2011
TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling
A Fiorio Pla, H L Ong, K T Cheng, et al.
Oncogene
|
June 21, 2011
Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP
T Oka, A P Schmitt, M Sudol
Oncogene
|
June 21, 2011
Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction
M Katsurano, T Niwa, Y Yasui, et al.
Oncogene
|
June 21, 2011
Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis
G Swaminathan, C A Cartwright
Oncogene
|
June 14, 2011
Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma
S-S Lo, P-S Hung, J-H Chen, et al.
Oncogene
|
June 14, 2011
Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP
L Angus, S Moleirinho, L Herron, et al.
Oncogene
|
June 14, 2011
Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment
L Heiska, M Melikova, F Zhao, et al.
Page
of 2,202
Search research articles
Search
Showing results (1191-1200 of 22,015) with videos related to
Sort By:
Page
of 2,202
Oncogene
|
April 19, 2011
MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma
Y Zhai, A Iura, S Yeasmin, et al.
Oncogene
|
April 19, 2011
Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression
C Giordano, S Catalano, S Panza, et al.
Oncogene
|
April 19, 2011
Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate
E Babu, S Ramachandran, V CoothanKandaswamy, et al.
Oncogene
|
June 21, 2011
TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling
A Fiorio Pla, H L Ong, K T Cheng, et al.
Oncogene
|
June 21, 2011
Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP
T Oka, A P Schmitt, M Sudol
Oncogene
|
June 21, 2011
Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction
M Katsurano, T Niwa, Y Yasui, et al.
Oncogene
|
June 21, 2011
Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis
G Swaminathan, C A Cartwright
Oncogene
|
June 14, 2011
Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma
S-S Lo, P-S Hung, J-H Chen, et al.
Oncogene
|
June 14, 2011
Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP
L Angus, S Moleirinho, L Herron, et al.
Oncogene
|
June 14, 2011
Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment
L Heiska, M Melikova, F Zhao, et al.
Page
of 2,202